Gene polymorphisms involved in the regulation of bone quality

References

• Riggs B L, Melton L J. The world-wide problem of osteoporosis: insights afforded by epidemiology. Bone 1995; 17(5 Suppl)506S–511S
   Google Scholar
• Center J R, Nguyen T V, Schneider D, Sambrook P N, Eisman J A. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999; 353: 878–882
   PubMed Web of Science ®Google Scholar
• Johnell O, Kanis J A. An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int 2004; 15: 897–902
   PubMed Web of Science ®Google Scholar
• Davies J H, Evans B AJ, Gregory J W. Bone mass acquisition in healthy children. Arch Dis Child 2005; 90: 373–378
   PubMed Web of Science ®Google Scholar
• Wainwright S A, Marshall L M, Ensrud K E, Cauley J A, Black D M, Hillier T A, Hochberg M C, Vogt M T, Orwoll E S. Study of Osteoporotic Fractures Research Group. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 2005; 90: 2787–2793
   PubMed Web of Science ®Google Scholar
• Cummings S R, Bates D, Black D M. Clinical use of bone densitometry: scientific review. J Am Med Assoc 2002; 288: 1889–1897
   PubMed Web of Science ®Google Scholar
• Soroko S B, Barrett-Connor E, Edelstein S L, Kritz-Silverstein D. Family history of osteoporosis and bone mineral density at the axial skeleton: the Rancho Bernardo study. J Bone Miner Res 1994; 9: 761–769
   PubMed Web of Science ®Google Scholar
• Nguyen T V, Eisman J A. Genetics of fractures: challenges and opportunities. J Bone Miner Res 2000; 15: 1253–1256
   PubMedGoogle Scholar
• Kaptoge S, Benevolenskaya L I, Bhalla A K, Cannata J B, Boonen S, Falch J A, Felsenberg D, Finn J D, Nuti R, Hoszowski K, et al. Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study. Bone 2005; 36: 387–398
   PubMedGoogle Scholar
• Ralston S H. Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab 2002; 87: 2460–2466
   PubMed Web of Science ®Google Scholar
• Peacock M, Turner C H, Econs M J, Foroud T. Genetics of osteoporosis. Endocr Rev 2002; 23: 303–326
   PubMed Web of Science ®Google Scholar
• Thijssen J HH. Overview on the effects of progestins on bone. Maturitas 2003; 46(Suppl 1)S77–S87
   Google Scholar
• Michaëlsson K, Melhus H, Ferm H, Ahlbom A, Pedersen N L. Genetic liability to fractures in the elderly. Arch Intern Med 2005; 185: 1825–1830
   Google Scholar
• Gennari L, Becherini L, Falchetti A, Masi L, Massart F, Brandi M L. Genetics of osteoporosis: role of steroid hormone receptor polymorphisms. J Steroid Biochem Mol Biol 2002; 81: 1–24
   PubMed Web of Science ®Google Scholar
• Uitterlinden A G, Fang Y, Van Meurs J B, Pols H A, Van Leeuwen J P. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338: 143–156
   PubMed Web of Science ®Google Scholar
• Thakkinstian A, D'Este C, Eisman J, Nguyen T, Attia J. Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res 2004; 19: 419–428
   PubMed Web of Science ®Google Scholar
• Abrams S A, Griffin I J, Hawthorne K M, Chen Z, Gunn S K, Wilde M, Darlington G, Shypailo R J, Ellis K J. Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty. J Bone Miner Res 2005; 20: 945–953
   PubMed Web of Science ®Google Scholar
• Rabon-Stith K M, Hagberg J M, Phares D A, Kostek M C, Delmonico M J, Roth S M, Ferrell R E, Conway J M, Ryan A S, Hurley B F. Vitamin D receptor FokI genotype influences bone mineral density response to strength training. Exp Physiol 2005; 90: 653–661
   PubMedGoogle Scholar
• Xu H, Xiong D H, Xu F H, Zhang Y Y, Lei S F, Deng H W. Association between VDR ApaI polymorphism and hip bone mineral density can be modified by body mass index: a study on postmenopausal Chinese women. Acta Biochim Biophys Sin (Shanghai) 2005; 37: 61–67
   PubMedGoogle Scholar
• Kammerer C M, Dualan A A, Samollow P B, Perisse A R, Bauer R L, MacCluer J W, O'Leary D H, Mitchell B D. Bone mineral density, carotid artery intimal medial thickness, and the vitamin D receptor BsmI polymorphism in Mexican American women. Calcif Tissue Int 2004; 75: 292–298
   PubMedGoogle Scholar
• Garnero P, Munoz F, Borel O, Sornay-Rendu E, Delmas P D. Vitamin D receptor gene polymorphisms are associated with the risk of fractures in postmenopausal women, independently of bone mineral density. J Clin Endocrinol Metab 2005; 90: 4829–4835
   PubMed Web of Science ®Google Scholar
• Gennari L, Merlotti D, De Paola V, Calabro A, Becherini L, Martini G, Nuti R. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am J Epidemiol 2005; 161: 307–320
   PubMed Web of Science ®Google Scholar
• Albagha O M, Pettersson U, Stewart A, McGuigan F E, MacDonald H M, Reid D M, Ralston S H. Association of oestrogen receptor α gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone. J Med Genet 2005; 42: 240–246
   PubMed Web of Science ®Google Scholar
• Nam H S, Shin M H, Kweon S S, Park K S, Sohn S J, Rhee J A, Choi J S, Son M H. Association of estrogen receptor-α gene polymorphisms with bone mineral density in postmenopausal Korean women. J Bone Miner Metab 2005; 23: 84–89
   PubMed Web of Science ®Google Scholar
• Heilberg I P, Hernandez E, Alonzo E, Valera R, Ferreira L G, Gomes S A, Bellorin-Font E, Weisinger J R. Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis. Ren Fail 2005; 27: 155–161
   PubMed Web of Science ®Google Scholar
• Ioannidis J P, Ralston S H, Bennett S T, Brandi M L, Grinberg D, Karassa F B, Langdahl B, van Meurs J B, Mosekilde L, Scollen S, et al. GENOMOS Study. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. J Am Med Assoc 2004; 292: 2105–2114
   PubMed Web of Science ®Google Scholar
• Malacara J M, Perez-Luque E L, Martinez-Garza S, Sanchez-Marin F J. The relationship of estrogen receptor-α polymorphism with symptoms and other characteristics in post-menopausal women. Maturitas 2004; 49: 163–169
   PubMed Web of Science ®Google Scholar
• Scariano J K, Simplicio S G, Montoya G D, Garry P J, Baumgartner R N. Estrogen receptor β dinucleotide (CA) repeat polymorphism is significantly associated with bone mineral density in postmenopausal women. Calcif Tissue Int 2004; 74: 501–508
   PubMed Web of Science ®Google Scholar
• Shearman A M, Karasik D, Gruenthal K M, Demissie S, Cupples L A, Housman D E, Kiel D P. Estrogen receptor β polymorphisms are associated with bone mass in women and men: the Framingham Study. J Bone Miner Res 2004; 19: 773–781
   PubMed Web of Science ®Google Scholar
• Yamada Y, Ando F, Niino N, Shimokata H. Association of polymorphisms of the androgen receptor and klotho genes with bone mineral density in Japanese women. J Mol Med 2005; 83: 50–57
   PubMedGoogle Scholar
• Langdahl B L, Stenkjaer L, Carstens M, Tofteng C L, Eriksen E F. A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures. Calcif Tissue Int 2003; 73: 237–243
   PubMedGoogle Scholar
• van Rossum E F, Lamberts S W. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res 2004; 59: 333–357
   PubMedGoogle Scholar
• Jiao J, Meng X W, Xing X P, Zhou X Y, Li M, Xia W B, Xu L, Tian J P, Yu W. [Bone mineral density and leptin receptor polymorphism Gln223Arg in Han women in Beijing]. Zhonghua Nei Ke Za Zhi 2004; 43: 276–279
   PubMedGoogle Scholar
• Bollerslev J, Wilson S G, Dick I M, Islam F M, Ueland T, Palmer L, Devine A, Prince R L. LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. Bone 2005; 36: 599–606
   PubMed Web of Science ®Google Scholar
• Koay M A, Woon P Y, Zhang Y, Miles L J, Duncan E L, Ralston S H, Compston J E, Cooper C, Keen R, Langdahl B L, et al. Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res 2004; 19: 1619–1627
   PubMedGoogle Scholar
• Urano T, Shiraki M, Ezura Y, Fujita M, Sekine E, Hoshino S, Hosoi T, Orimo H, Emi M, Ouchi Y, et al. Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density. J Bone Miner Metab 2004; 22: 341–345
   PubMed Web of Science ®Google Scholar
• Ferrari S L, Deutsch S, Choudhury U, Chevalley T, Bonjour J P, Dermitzakis E T, Rizzoli R, Antonarakis S E. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet 2004; 74: 866–875
   PubMed Web of Science ®Google Scholar
• Li D, Dong Z W, Xue T, Wang Q. [Association study of RFLP of parathyroid hormone gene and bone mineral density in postmenopausal women]. Yi Chuan 2003; 25: 133–136
   PubMedGoogle Scholar
• Xu H, Zhao L J, Lei S F, Li M X, Sun X, Deng F Y, Jiang D K, Deng H W. The (CA)n polymorphism of the TNFR2 gene is associated with peak bone density in Chinese nuclear families. J Hum Genet 2005; 50: 301–304
   PubMedGoogle Scholar
• Tasker P N, Albagha O M, Masson C B, Reid D M, Ralston S H. Association between TNFRSF1B polymorphisms and bone mineral density, bone loss and fracture. Osteoporos Int 2004; 15: 903–908
   PubMedGoogle Scholar
• Hoshino S, Ouchi Y. [Tumor necrosis factor receptor (TNFR) gene polymorphism]. Nippon Rinsho 2004; 62(Suppl 2)173–177
   PubMedGoogle Scholar
• Kim J G, Choi Y M, Moon S Y, Lee Y J. Association of the calcitonin gene (CA) polymorphism with bone mass and bone responsiveness to hormone therapy in postmenopausal Korean women. Menopause 2003; 10: 544–549
   PubMed Web of Science ®Google Scholar
• Zofkova I, Zajickova K, Hill M, Krepelova A. Does polymorphism C1377T of the calcitonin receptor gene determine bone mineral density in postmenopausal women?. Exp Clin Endocrinol Diabetes 2003; 111: 447–449
   PubMedGoogle Scholar
• Bandres E, Pombo I, Gonzalez-Huarriz M, Rebollo A, Lopez G, Garcia-Foncillas J. Association between bone mineral density and polymorphisms of the VDR, ERα, COL1A1 and CTR genes in Spanish postmenopausal women. J Endocrinol Invest 2005; 28: 312–321
   PubMedGoogle Scholar
• Abe E, Marians R C, Yu W, Wu X B, Ando T, Li Y, Iqbal J, Eldeiry L, Rajendren G, Blair H C, et al. TSH is a negative regulator of skeletal remodelling. Cell 2003; 115: 129–130
   PubMedGoogle Scholar
• Yamada Y, Ando F, Niino N, Shimokata H. Association of a polymorphism of the dopamine receptor D4 gene with bone mineral density in Japanese men. J Hum Genet 2003; 48: 629–633
   PubMedGoogle Scholar
• Lau H H, Ho A Y, Luk K D, Kung A W. Transforming growth factor-β1 gene polymorphisms and bone turnover, bone mineral density and fracture risk in southern Chinese women. Calcif Tissue Int 2004; 74: 516–521
   PubMedGoogle Scholar
• Lau E M, Wong S Y, Li M, Ma C H, Lim P L, Woo J. Osteoporosis and transforming growth factor-β-1 gene polymorphism in Chinese men and women. J Bone Miner Metab 2004; 22: 148–152
   PubMedGoogle Scholar
• Rhee E J, Oh K W, Lee W Y, Kim S Y, Oh E S, Baek K H, Kang M I, Kim S W. The effects of C161→T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-γ gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women. Am J Obstet Gynecol 2005; 192: 1087–1093
   PubMed Web of Science ®Google Scholar
• Tomita M, Kurabayashi T, Tanaka K. [Association of β3-adrenergic receptor (β3-AR) gene polymorphism with osteoporosis]. Nippon Rinsho 2004; 62(Suppl 2)169–172
   PubMedGoogle Scholar
• Kim G S, Koh J M, Chang J S, Park B L, Kim L H, Park E K, Kim S Y, Shin H D. Association of the OSCAR promotor polymorphism with BMD in postmenopausal women. J Bone Mineral Res 2005; 20: 1342–1348
   PubMed Web of Science ®Google Scholar
• Lakatos P L, Bajnok E, Tornai I, Folhoffer A, Horvath A, Lakatos P, Habior A, Szalay F. Insulin-like growth factor I gene microsatellite repeat, collagen type Iα1 gene Sp1 polymorphism, and bone disease in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2004; 16: 753–759
   PubMedGoogle Scholar
• Rivadeneira F, Houwing-Duistermaat J J, Beck T J, Janssen J A, Hofman A, Pols H A, Van Duijn C M, Uitterlinden A G. The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of non-vertebral fracture in the elderly: the Rotterdam Study. J Bone Miner Res 2004; 191: 280–290
   Google Scholar
• Dennison E M, Syddall H E, Rodriguez S, Voropanov A, Day I N, Cooper C. Southampton Genetic Epidemiology Research Group. Polymorphism in the growth hormone gene, weight in infancy, and adult bone mass. J Clin Endocrinol Metab 2004; 89: 4898–4903
   PubMedGoogle Scholar
• Ezura Y, Nakajima T, Kajita M, Ishida R, Inoue S, Yoshida H, Suzuki T, Shiraki M, Hosoi T, Orimo H, et al. Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein (DBP) gene with postmenopausal bone mineral density. J Bone Miner Res 2003; 18: 1642–1649
   PubMed Web of Science ®Google Scholar
• Dennison E M, Syddall H E, Fall C H, Javaid M K, Arden N K, Phillips D I, Cooper C. Plasma leptin concentration and change in bone density among elderly men and women: the Herfordshire Cohort Study. Calcif Tissue Int 2004; 74: 401–406
   PubMed Web of Science ®Google Scholar
• Roux C, Arabi A, Porcher R, Garnero P. Serum leptin as a determinant of bone resorption in healthy postmenopausal women. Bone 2003; 33: 847–852
   PubMed Web of Science ®Google Scholar
• Koshihara Y. [Interleukin-6 gene polymorphism]. Nippon Rinsho 2004; 62(Suppl 2)179–185
   PubMedGoogle Scholar
• Moffett S P, Zmuda J M, Cauley J A, Stone K L, Nevitt M C, Ensrud K E, Hillier T A, Hochberg M C, Joslyn G, Morin P, et al. SOF Research Group. Association of the G-174C variant in the interleukin-6 promoter region with bone loss and fracture risk in older women. J Bone Miner Res 2004; 19: 1612–1618
   PubMedGoogle Scholar
• Furuta I, Kobayashi N, Fujino T, Kobamatsu Y, Shirogane T, Yaegashi M, Sakuragi N, Cho K, Yamada H, Okuyama K, et al. Bone mineral density of the lumbar spine is associated with TNF gene polymorphisms in early postmenopausal Japanese women. Calcif Tissue Int 2004; 74: 509–515
   PubMedGoogle Scholar
• Moffett S P, Zmuda J M, Oakley J I, Beck T J, Cauley J A, Stone K L, Lui L Y, Ensrud K E, Hillier T A, Hochberg M C, et al. Tumor necrosis factor-α polymorphism, bone strength phenotypes, and the risk of fracture in older women. J Clin Endocrinol Metab 2005; 90: 3491–3497
   PubMed Web of Science ®Google Scholar
• Long J R, Liu P Y, Lu Y, Dvornyk V, Xiong D H, Zhao L J, Deng H W. Tests of linkage and/or association of TGF-β1 and COL1A1 genes with bone mass. Osteoporos Int 2005; 16: 86–92
   PubMedGoogle Scholar
• Cheng Q, Zhu H M, Miao Y X, Zhu X Y, Chen X P, Zhang X M. [Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women]. Zhonghua Yi Xue Za Zhi 2004; 84: 274–277
   PubMedGoogle Scholar
• Zhao H Y, Liu J M, Ning G, Zhao Y J, Zhang L Z, Sun L H, Xu M Y, Uitterlinden A G, Chen J L. The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. Osteoporos Int 2005; 16: 1519–1524
   PubMedGoogle Scholar
• Arko B, Prezelj J, Kocijancic A, Komel R, Marc J. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women. Maturitas 2005; 51: 270–279
   PubMedGoogle Scholar
• Heikkinen A M, Niskanen L K, Salmi J A, Koulu M, Pesonen U, Uusitupa M I, Komulainen M H, Tuppurainen M T, Kroger H, Jurvelin J, et al. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women. Bone 2004; 35: 589–594
   PubMedGoogle Scholar
• Grundberg E, Carling T, Brandstrom H, Huang S, Ribom E L, Ljunggren O, Mallmin H, Kindmark A. A deletion polymorphism in the RIZ gene, a female sex steroid hormone receptor coactivator, exhibits decreased response to estrogen in vitro and associates with low bone mineral density in young Swedish women. J Clin Endocrinol Metab 2004; 89: 6173–6178
   PubMedGoogle Scholar
• Sudo Y, Ezura Y, Kajita M, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shiraki M, Ito H, Emi M. Association of single nucleotide polymorphisms in the promotor region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women. J Hum Genet 2005; 50: 235–240
   PubMedGoogle Scholar
• Gennari L, Masi L, Merlotti D, Picariello L, Falchetti A, Tanini A, Mavilia C, Del Monte F, Gonnelli S, Lucani B, et al. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. J Clin Endocrinol Metab 2004; 89: 2803–2810
   PubMed Web of Science ®Google Scholar
• Dick I M, Devine A, Prince R L. Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women. Am J Physiol Endocrinol Metab 2005; 288: E989–E995
   PubMed Web of Science ®Google Scholar
• Riancho J A, Zarrabeitia M T, Valero C, Sanudo C, Hernandez J L, Amado J A, Zarrabeitia A, Gonzalez-Macias J. Aromatase gene and osteoporosis: relationship of ten polymorphic loci with bone mineral density. Bone 2005; 36: 917–925
   PubMed Web of Science ®Google Scholar
• Zarrabeitia M T, Hernandez J L, Valero C, Zarrabeitia A L, Garcia-Unzueta M, Amado J A, Gonzalez-Macias J, Riancho J A. A common polymorphism in the 5′-untranslated region of the aromatase gene influences bone mass and fracture risk. Eur J Endocrinol 2004; 150: 699–704
   PubMed Web of Science ®Google Scholar
• Tofteng C L, Kindmark A, Brandstrom H, Abrahamsen B, Petersen S, Stiger F, Stilgren L S, Jensen J E, Vestergaard P, Langdahl B L, et al. Danish Osteoporosis Prevention Study. Polymorphisms in the CYP19 and AR genes – relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study. Calcif Tissue Int 2004; 74: 25–34
   PubMed Web of Science ®Google Scholar
• Somner J, McLellan S, Cheung J, Mak Y T, Frost M L, Knapp K M, Wierzbicki A S, Wheeler M, Fogelman I, Ralston S H, et al. Polymorphisms in the P450 c17 (17-hydroxylase/17,20-lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women. J Clin Endocrinol Metab 2004; 89: 344–351
   PubMed Web of Science ®Google Scholar
• Salmen T, Heikkinen A M, Mahonen A, Kroger H, Komulainen M, Pallonen H, Saarikoski S, Honkanen R, Maenpaa P H. Relation of aromatase gene polymorphism and hormone replacement therapy to serum estradiol levels, bone mineral density, and fracture risk in early postmenopausal women. Ann Med 2003; 35: 282–288
   PubMed Web of Science ®Google Scholar
• Sharp L, Cardy A H, Cotton S C, Little J. CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. a HuGE review. Am J Epidemiol 2004; 160: 729–740
   PubMed Web of Science ®Google Scholar
• Zhang Z L, Qin Y J, He J W, Huang Q R, Zhou Q, Hu Y Q, Li M, Liu Y J. [Relationship of msp AI polymorphism in cytochrome P450c 17α gene with bone mass and bone size in Shanghai men of Han nationality]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2004; 26: 687–691
   PubMedGoogle Scholar
• Napoli N, Villareal D T, Mumm S, Halstead L, Sheikh S, Cagaanan M, Rini G B, Armamento-Villareal R. Effect of CYP1A1 gene polymorphisms on estrogen metabolism and bone density. J Bone Miner Res 2005; 20: 232–239
   PubMed Web of Science ®Google Scholar
• Tofteng C L, Abrahamsen B, Jensen J E, Petersen S, Teilmann J, Kindmark A, Vestergaard P, Gram J, Langdahl B L, Mosekilde L. Two single nucleotide polymorphisms in the CYP17 and COMT genes – relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy. The Danish Osteoporosis Prevention Study. Calcif Tissue Int 2004; 75: 123–132
   PubMedGoogle Scholar
• Lorentzon M, Eriksson A L, Mellstrom D, Ohlsson C. The COMT val158met polymorphism is associated with peak BMD in men. J Bone Miner Res 2004; 19: 2005–2011
   PubMedGoogle Scholar
• Reneland R H, Mah S, Kammerer S, Hoyal C R, Marnellos G, Wilson S G, Sambrook P N, Spector T D, Nelson M R, Braun A. Association between a variation in the phosphodiesterase 4D gene and bone mineral density. BMC Med Genet 2005; 6: 9
   PubMed Web of Science ®Google Scholar
• Goseki-Sone M, Sogabe N, Fukushi-Irie M, Mizoi L, Orimo H, Suzuki T, Nakamura H, Orimo H, Hosoi T. Functional analysis of the single nucleotide polymorphism (787T→C) in the tissue-nonspecific alkaline phosphatase gene associated with BMD. J Bone Miner Res 2005; 20: 773–782
   PubMedGoogle Scholar
• Krylov M Iu, Korotkova T A, Miakotkin V A, Benevolenskaia L I. [Allele polymorphism of alkaline phosphatase, acid soluble phosphatase, and vitamin D-binding protein genes in postmenopausal osteoporosis]. Ter Arkh 2004; 76: 61–65
   PubMedGoogle Scholar
• Urano T, Shiraki M, Fujita M, Hosoi T, Orimo H, Ouchi Y, Inoue S. Association of a single nucleotide polymorphism in the lipoxygenase ALOX15 5′-flanking region (–5229G/A) with bone mineral density. J Bone Miner Metab 2005; 23: 226–230
   PubMed Web of Science ®Google Scholar
• Lee S I, Lee S Y, Yoo W H. Association of apolipoprotein E polymorphism with bone mineral density in postmenopausal women with rheumatoid arthritis. Rheumatology (Oxford) 2005; 44: 1067–1068
   PubMedGoogle Scholar
• Wong S Y, Lau E M, Li M, Chung T, Sham A, Woo J. The prevalence of Apo E4 genotype and its relationship to bone mineral density in Hong Kong Chinese. J Bone Miner Metab 2005; 23: 261–265
   PubMedGoogle Scholar
• Schoofs M W, van der Klift M, Hofman A, van Duijn C M, Stricker B H, Pols H A, Uitterlinden A G. ApoE gene polymorphisms, BMD, and fracture risk in elderly men and women: the Rotterdam study. J Bone Miner Res 2004; 19: 1490–1496
   PubMedGoogle Scholar
• Souto J C, Blanco-Vaca F, Soria J M, Buil A, Almasy L, Ordonez-Llanos J, Martin-Campos J M, Lathrop M, Stone W, Blangero J, et al. A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project. Am J Hum Genet 2005; 76: 925–933
   PubMedGoogle Scholar
• Villadsen M M, Bunger M H, Carstens M, Stenkjaer L, Langdahl B L. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD. Osteoporos Int 2005; 16: 411–416
   PubMed Web of Science ®Google Scholar
• Macdonald H M, McGuigan F E, Fraser W D, New S A, Ralston S H, Reid D M. Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density. Bone 2004; 35: 957–964
   PubMed Web of Science ®Google Scholar
• Li M, Lau E M, Woo J. Methylenetetrahydrofolate reductase polymorphism (MTHFR C677T) and bone mineral density in Chinese men and women. Bone 2004; 35: 1369–1374
   PubMedGoogle Scholar
• McLean R R, Karasik D, Selhub J, Tucker K L, Ordovas J M, Russo G T, Cupples L A, Jacques P F, Kiel D P. Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J Bone Miner Res 2004; 19: 410–418
   PubMedGoogle Scholar
• Golbahar J, Hamidi A, Aminzadeh M A, Omrani G R. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study. Bone 2004; 35: 760–765
   PubMedGoogle Scholar
• Altun B, Kiykim A A, Seyrantepe V, Usalan C, Arici M, Caglar M, Erdem Y, Yasavul U, Turgan C, Caglar S. Association between activated renin angiotensin system and bone formation in hemodialysis patients: is the bone mass genetically determined by ACE gene polymorphism?. Ren Fail 2004; 26: 425–431
   PubMed Web of Science ®Google Scholar
• Martignetti J A, Aqeel A A, Sewairi W A, Boumah C E, Kambouris M, Mayouf S A, Sheth K V, Eid W A, Dowling O, Harris J, et al. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 2001; 28: 261–265
   PubMed Web of Science ®Google Scholar
• Yamada Y, Ando F, Niino N, Shimokata H. Association of a polymorphism of the matrix metalloproteinase-9 gene with bone mineral density in Japanese men. Metabolism 2004; 53: 135–137
   PubMedGoogle Scholar
• Yamada Y, Ando F, Niino N, Miki T, Shimokata H. Association of polymorphisms of paraoxonase 1 and 2 genes, alone or in combination, with bone mineral density in community-dwelling Japanese. J Hum Genet 2003; 48: 469–475
   PubMed Web of Science ®Google Scholar
• Ezura Y, Kajita M, Ishida R, Yoshida S, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shiraki M, Orimo H, et al. Association of multiple nucleotide variations in the pituitary glutaminyl cyclase gene (QPCT) with low radial BMD in adult women. J Bone Miner Res 2004; 19: 1296–1301
   PubMed Web of Science ®Google Scholar
• Giraudeau F S, McGinnis R E, Gray I C, O'Brien E J, Doncaster K E, Spurr N K, Ralston S H, Reid D M, Wood J. Characterization of common genetic variants in cathepsin K and testing for association with bone mineral density in a large cohort of perimenopausal women from Scotland. J Bone Miner Res 2004; 19: 31–41
   PubMedGoogle Scholar
• Kawano K, Kawaguchi H. [Human klotho gene polymorphisms associated with bone density of aged postmenopausal women]. Nippon Rinsho 2004; 62(Suppl 2)190–194
   PubMedGoogle Scholar
• Enattah N S, Sulkava R, Halonen P, Kontula K, Jarvela I. Genetic variant of lactase-persistent C/T-13910 is associated with bone fractures in very old age. J Am Geriatr Soc 2005; 53: 79–82
   PubMedGoogle Scholar
• Stewart T L, Roschger P, Misof B M, Mann V, Fratzl P, Klaushofer K, Aspden R, Ralston S H. Association of COLIA1 Sp1 alleles with defective bone nodule formation in vitro and abnormal bone mineralization in vivo. Calcif Tissue Int 2005; 77: 113–118
   PubMedGoogle Scholar
• Lian K, Zmuda J M, Nevitt M C, Lui L, Hochberg M C, Greene D, Li J, Wang J, Lane N E. Type I collagen α1 Sp1 transcription factor binding site polymorphism is associated with reduced risk of hip osteoarthritis defined by severe joint space narrowing in elderly women. Arthritis Rheum 2005; 52: 1431–1436
   PubMedGoogle Scholar
• Yamada Y, Ando F, Niino N, Shimokata H. Association of a –1997G→T polymorphism of the collagen Iα1 gene with bone mineral density in postmenopausal Japanese women. Hum Biol 2005; 77: 27–36
   PubMed Web of Science ®Google Scholar
• Zhang Y Y, Lei S F, Mo X Y, Wang Y B, Li M X, Deng H W. The – 1997 G/T polymorphism in the COLIA1 upstream regulatory region is associated with hip bone mineral density (BMD) in Chinese nuclear families. Calcif Tissue Int 2005; 76: 107–112
   PubMedGoogle Scholar
• Weichetova M, Stepan J J, Haas T, Michalska D. The risk of Colles' fracture is associated with the collagen I α1 Sp1 polymorphism and ultrasound transmission velocity in the calcaneus only in heavier postmenopausal women. Calcif Tissue Int 2005; 76: 98–106
   PubMedGoogle Scholar
• Pluijm S M, van Essen H W, Bravenboer N, Uitterlinden A G, Smit J H, Pols H A, Lips P. Collagen type I α1 Sp1 polymorphism, osteoporosis, and intervertebral disc degeneration in older men and women. Ann Rheum Dis 2004; 63: 71–77
   PubMed Web of Science ®Google Scholar
• Lau E M, Choy D T, Li M, Woo J, Chung T, Sham A. The relationship between COLI A1 polymorphisms (Sp 1) and COLI A2 polymorphisms (Eco R1 and Puv II) with bone mineral density in Chinese men and women. Calcif Tissue Int 2004; 75: 133–137
   PubMedGoogle Scholar
• Lei S F, Deng F Y, Dvornyk V, Liu M Y, Xiao S M, Jiang D K, Deng H W. The (GT)n polymorphism and haplotype of the COL1A2 gene, but not the (AAAG)n polymorphism of the PTHR1 gene, are associated with bone mineral density in Chinese. Hum Genet 2005; 116: 200–207
   PubMedGoogle Scholar
• Gustavsson A, Nordstrom P, Lorentzon R, Lerner U H, Lorentzon M. Osteocalcin gene polymorphism is related to bone density in healthy adult females. Osteoporos Int 2000; 11: 847–850
   PubMed Web of Science ®Google Scholar
• Sobacchi C, Vezzoni P, Reid D M, McGuigan F E, Frattini A, Mirolo M, Albhaga O M, Musio A, Villa A, Ralston S H. Association between a polymorphism affecting an AP1 binding site in the promoter of the TCIRG1 gene and bone mass in women. Calcif Tissue Int 2004; 74: 35–41
   PubMedGoogle Scholar
• Styrkarsdottir U, Cazier J B, Kong A, Rolfsson O, Larsen H, Bjarnadottir E, Johannsdottir V D, Sigurdardottir M S, Bagger Y, Christiansen C, et al. Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol 2003; 1: E69
   PubMed Web of Science ®Google Scholar
• Zmuda J M, Sheu Y T, Moffett S P. Genetic epidemiology of osteoporosis: past, present and future. Curr Osteoporos Rep 2005; 3: 111–115
   PubMedGoogle Scholar
• Ramesh Babu L, Wilson S G, Dick I M, Islam F M, Devine A, Prince R L. Bone mass effects of a BMP4 gene polymorphism in postmenopausal women. Bone 2005; 36: 555–561
   PubMedGoogle Scholar
• Uitterlinden A G, Arp P P, Paeper B W, Charmley P, Proll S, Rivadeneira F, Fang Y, van Meurs J B, Britschgi T B, Latham J A, et al. Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites. Am J Hum Genet 2004; 75: 1032–1045
   PubMedGoogle Scholar
• Loughlin J, Dowling B, Chapman K, Marcelline L, Mustafa Z, Southam L, Ferreira A, Ciesielski C, Carson D A, Corr M. Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Proc Natl Acad Sci U S A 2004; 101: 9757–9762
   PubMed Web of Science ®Google Scholar
• Turner R T, Riggs B L, Spelsberg T C. Skeletal effects of estrogen. Endocr Rev 1994; 15: 275–300
   PubMed Web of Science ®Google Scholar
• Khosla S, Melton L J, Riggs B L. Clinical Review 144: Estrogen and the male skeleton. J Clin Endocrinol Metab 2002; 87: 1443–1450
   PubMed Web of Science ®Google Scholar
• Compston J E. Sex steroids and bone. Physiol Rev 2001; 81: 419–447
   PubMed Web of Science ®Google Scholar
• Sowers M, Willing M, Burns T, Deschenes S, Hollis B, Crutchfield M, Jannausch M. Genetic markers, bone mineral density and serum osteocalcin levels. J Bone Miner Res 1999; 14: 1411–1419
   PubMed Web of Science ®Google Scholar
• Zitzmann M, Brune M, Kornmann B, Gromoll J, Junker R, Nieschlag E. The CAG repeat polymorphism in the androgen receptor affects bone density and bone metabolism in healthy males. Clin Endocrinol (Oxf) 2001; 55: 649–657
   PubMed Web of Science ®Google Scholar
• Miyaura C, Toda K, Inada M, Ohshiba T, Matsumoto C, Okada T, Ito M, Shizuta Y, Ito A. Sex- and age-related response to aromatase deficiency in bone. Biochem Biophys Res Commun 2001; 280: 1062–1068
   PubMed Web of Science ®Google Scholar
• Morishima A, Grumbach M M, Simpson E R, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995; 80: 3689–3698
   PubMed Web of Science ®Google Scholar
• Mullis P E, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P, Harada H. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries and bone densitometry in childhood. J Clin Endocrinol Metab 1997; 82: 1739–1745
   PubMed Web of Science ®Google Scholar
• Karsenty G, Park R W. Regulation of type I collagen genes expression. Int Rev Immunol 1995; 12: 177–185
   PubMedGoogle Scholar
• Lei S F, Wang Y B, Liu M Y, Mo X Y, Deng H W. The VDR, COL1A1, PTH, and PTHR1 gene polymorphisms are not associated with bone size and height in Chinese nuclear families. J Bone Miner Metab 2005; 23: 501–505
   PubMedGoogle Scholar
• Mann V, Ralston S H. Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone 2003; 32: 711–717
   PubMed Web of Science ®Google Scholar
• Rubenstein W S, Roy H K. Practicing medicine at the front lines of the genomic revolution. Arch Intern Med 2005; 165: 1815–1817
   PubMedGoogle Scholar